Haisike(002653.SZ) receives the acceptance notice for the listing approval of the innovative drug HSK39297 tablets

Zhitong Finance APP News, Hisco (002653.SZ) announced that its subsidiary, Sichuan Hisco Pharmaceutical Co., Ltd., recently received the HSK39297 “Acceptance Notice” issued by the National Medical Products Administration. This drug is used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adult patients.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin